These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23030234)

  • 1. Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.
    Rietjens SJ; Hondebrink L; Westerink RH; Meulenbelt J
    Crit Rev Toxicol; 2012 Nov; 42(10):854-76. PubMed ID: 23030234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
    Farré M; Abanades S; Roset PN; Peiró AM; Torrens M; O'Mathúna B; Segura M; de la Torre R
    J Pharmacol Exp Ther; 2007 Dec; 323(3):954-62. PubMed ID: 17890444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex.
    Hysek CM; Liechti ME
    Psychopharmacology (Berl); 2012 Dec; 224(3):363-76. PubMed ID: 22700038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.
    Hysek C; Schmid Y; Rickli A; Simmler LD; Donzelli M; Grouzmann E; Liechti ME
    Br J Pharmacol; 2012 Aug; 166(8):2277-88. PubMed ID: 22404145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT).
    Pardo-Lozano R; Farré M; Yubero-Lahoz S; O'Mathúna B; Torrens M; Mustata C; Pérez-Mañá C; Langohr K; Cuyàs E; Carbó Ml; de la Torre R
    PLoS One; 2012; 7(10):e47599. PubMed ID: 23112822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.
    Liechti ME; Geyer MA; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2001 Mar; 24(3):240-52. PubMed ID: 11166515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
    Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2000 Oct; 23(4):396-404. PubMed ID: 10989266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecstasy: pharmacodynamic and pharmacokinetic interactions.
    Oesterheld JR; Armstrong SC; Cozza KL
    Psychosomatics; 2004; 45(1):84-7. PubMed ID: 14709765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics.
    Sehrt D; Meineke I; Tzvetkov M; Gültepe S; Brockmöller J
    Pharmacogenomics; 2011 Jun; 12(6):783-95. PubMed ID: 21599570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.
    Liechti ME; Vollenweider FX
    J Psychopharmacol; 2000; 14(3):269-74. PubMed ID: 11106307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.
    Callaghan PD; Irvine RJ; Daws LC
    Neurochem Int; 2005 Oct; 47(5):350-61. PubMed ID: 15979209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contractile effects of 3,4-methylenedioxymethamphetamine on the human internal mammary artery.
    Silva S; Carvalho F; Fernandes E; Antunes MJ; Cotrim MD
    Toxicol In Vitro; 2016 Aug; 34():187-193. PubMed ID: 27079619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.
    Liechti ME; Vollenweider FX
    Eur Neuropsychopharmacol; 2000 Jul; 10(4):289-95. PubMed ID: 10871712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
    Fantegrossi WE; Godlewski T; Karabenick RL; Stephens JM; Ullrich T; Rice KC; Woods JH
    Psychopharmacology (Berl); 2003 Mar; 166(3):202-11. PubMed ID: 12563544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.
    Hysek CM; Brugger R; Simmler LD; Bruggisser M; Donzelli M; Grouzmann E; Hoener MC; Liechti ME
    J Pharmacol Exp Ther; 2012 Feb; 340(2):286-94. PubMed ID: 22034656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.
    Rolle A; Takematsu M; Hoffman R
    Br J Pharmacol; 2013 Nov; 170(6):1272. PubMed ID: 24571430
    [No Abstract]   [Full Text] [Related]  

  • 19. Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model.
    Sprague JE; Moze P; Caden D; Rusyniak DE; Holmes C; Goldstein DS; Mills EM
    Crit Care Med; 2005 Jun; 33(6):1311-6. PubMed ID: 15942349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
    Kiyatkin EA; Ren SE
    Curr Top Behav Neurosci; 2017; 32():183-207. PubMed ID: 27677782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.